France· FR:68470152
TAMSULOSINE ARROW LP 0,4 mg, comprimé à libération prolongée
A tamsulosin product containing chlorhydrate de tamsulosine, registered in France by ARROW GENERIQUES, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Tamsulosin is registered in 17 of 19 countries.
Countries holding a registration under ATC G04CA02 (tamsulosin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 11 of them publish a price we can compare per daily dose
Tamsulosin · ATC G04CA02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tamsulosin costs, country by country.
Normalised to the WHO defined daily dose (0.4 mg), the median price runs from $0.17 in France to $1.11 in Switzerland — a ×6.5 gap.
- France: $0.17 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Tamsulosin · price per daily dose (0.4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.11
- ES Spain$0.42
- IT Italy$0.25
- FR France$0.17
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE TAMSULOSINE
- Manufacturer
- ARROW GENERIQUES
- Country
- France (FR)
- ATC code
- G04CA02
- ATC class
- Tamsulosin
- Defined daily dose
- 0.4 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930218525plaquette(s) aluminium de 30 comprimé(s)EUR 4.52
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
311 interactions on record for tamsulosin.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tamsulosin · interactions on record
311 records
- 9 severe
- 101 moderate
- 1 minor
- 168 info
Most severe, free to view
- KetoconazoleH02CA03severe
- ClarithromycinJ01FA09severe
- KetoconazoleJ02AB02severe
- Darunavir and cobicistatJ05AR14severe
32 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tamsulosin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaOMNIC TOCASAstellas Pharma s.r.o., Praha
- SpainINREQ 0,4 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFGLaboratorios Q Pharma S.L.
- United KingdomCositam XL 400microgram tabletsConsilient Health Ltd
- NetherlandsOmnic Ocas 0,4, tabletten met verlengde afgifte 0,4 mgAstellas Pharma Europe B.V.
- PolandAdatam XRAdamed Pharma S.A.
- BelgiumOmic Ocas 0,4 mgImpexeco
- CanadaAPO-TAMSULOSIN CRAPOTEX INC
- FinlandMasulinSandoz A/S
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Aglandin Retard, Tamsu
- Belgium · Omic Ocas, Ranomax
- Bulgaria · Tamaliz, Омник Токас
- Cyprus · Tamsulijn, Tamsulosin Aurobindo
- Czechia · Fokusin, Lannatam
- Germany · Omnic Ocas, Prostadil
- Denmark · Bladasin, Miktosan
- Estonia · Flosin, Omsal
- Spain · Inreq, Omnic
- Finland · Expros, Omnic Ocas
- United Kingdom (Northern Ireland) · Contiflo Xl, Cositam Xl
- Greece · Omnic Τocas, Prosolvin
- Croatia · Bazetham, Flosin
- Hungary · Galebon, Omnic
- Ireland · Omnexel, Tamnexyl Xl
- Iceland · Tamsulosin Hydrochloride Synthon, Tamsulosin Medical
- Italy · Antunes, Botam
- Lithuania · Flosin, Fokusin
- Luxembourg · Omic Ocas, Ranomax
- Latvia · Fokusin, Tamsulosin Lannacher
- Malta · Tamnic, Tamnic 400 Micrograms Modified-Release Capsules, Hard
- Netherlands · Duktam, Omnic 0,4
- Norway · Miktosan, Omnic
- Poland · Adatam, Adatam Xr
- Portugal · Omnic, Sebrane Xr
- Romania · Contiflo Mr, Fokusin
- Sweden · Tamicten
- Slovenia · Miktan, Omnic Ocas
- Slovakia · Fokusin, Geroprostan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ce52daff-96f5-4571-b594-39522565f7eb GET /v1/drugs/ce52daff-96f5-4571-b594-39522565f7eb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68470152",
"date_amm": "2020-11-26",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "CHLORHYDRATE DE TAMSULOSINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé à libération prolongée",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about tamsulosin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.